Check out the participants for Academia-Industry Training 2018

Meet all the participants and their startups

These are the Swiss and Brazilian researchers selected for the next edition of the Academia-Industry Training 2018. They will take part in the program that will take place in November in Brazil and in April, 2019, in Switzerland. The selected startups cover various industries such as AgriTech, Big Data, Construction, Education, FinTech, Foodtech, MedTech, SaaS and consist of Master, PhD and PostDoc students.

The AIT is a highly recognized program that connects promising researchers-entrepreneurs from Switzerland and Brazil with the industry to develop the market application of their high-level research. The program encourages international researchers to work together, share best practices, and to understand new markets and exploit synergies. The one-week Training Camp gives a substantial introduction to entrepreneurship featuring workshops in business plan writing, market-entry scenarios, funding strategies and pitching classes as well as a thorough understanding of Brazilian and Swiss market opportunities.

Swiss Participants

Florent Héroquel (Bloom / EPFL)
Bloom patented technology is the first process able to extract all the value from plants, opening the possibility for sustainable valorisation of plants wastes to high value chemicals.

Etienne Jeoffroy (FenX / ETH Zürich)
We want to disrupt the building insulation market by transforming abandoned mineral waste into high- performance insulation foams complying with the recent health and environmental regulations.

Gnanli Landrou (Oxara/ ETH Zürich)
The cement-free concrete technology developed during my PhD helps transforming excavation materials and construction waste (buildings rubbles) into sustainable concrete: low cost, low CO2 for affordable and residential housings market.

Jonas Pollard (Hemolytics / Université de Fribourg)
A malaria diagnostic enabling eradication campaigns by allowing population screening and detection of asymptomatic carriers with low infections.

Jean-Pascal Aribot (AgroSustain / EPFL)
Innovative product to reduce food wastage by preventing development of fungal pathogens on fruits and vegetables.

Caio Guedes Braguine (MyOwn / Unifran)
Use of AI in the Identification of neglected tropical diseases with x-ray and blood test images analysis.

Jonathan Fiorentini (HiLyte / University of St.Gallen)
We are developing state-of-the-art educational science kits to help raise new generations of clean tech pioneers.

Noémie Widmer (EarthAidSolutions / University of St.Gallen)
An hectare of bamboo planted a day, keeps global warming away!

Carlos Vargas (Investimentos Verdes / University of Zurich)
Investimentos Verdes investments for everyone, at the touch of your fingertips // Investimentos Verdes para todos, ao toque de seus dedos.

André Dahlinger (Avertu / ETH Zurich)
At Avertu we want to save lives by bringing data-driven road safety to the world.

Ana Ferronato (NetWord / IFFluminense)
IoT monitoring of soil and crops spatial variation, generating agronomic prescription at variable rates to reduce costs per hectare.

Carlo Rondinoni (Tagma / InRad/FMUSP)
An Augmented Reality (AR) coloured head cap aims at the on-site medical visualization by depicting the brain shape and functional areas along with an Android app, which in turn shows the 3D virtual brain for training and neuronavigation.

Elyr Alves (Senfio / UFRJ)
Reduction of deaths caused by hospital infection. Save lives, clean your hands.

Fabiana Noronha Dornelles (Tech Pain / UFSC)
TechPain is the revolution of chronic joint pain treatment in arthritis through a non-invasive and self-controlled nanodrug delivery system.

Guilherme Souza ( MDev Medical Devices / Unesp)
A light curing device for composite resins applied in dental restorations able to improve the quality, longevity and stability of the restoration.

Joao Longo (Nanoceuticals / Universidade de Brasília)
Nanoceuticals develops high-performance inputs and ingredients for the cosmetics industry using nanotechnology.

Marcos Valadares (Pluricell / USP)
We are developing a cell therapy for people with heart problems by producing real human heart cells in the lab to be injected to their heart and improve its function.

Renata Fernandes (BioBreyer / Unesp)
BioBreyer develops a pharmaceutical to treat leukemia: new generation asparaginase, based in rational design and nanotechnology.

Stephanie Morais ( LifeProt / Fiocruz-PR, Carlos Chagas Institute)
Delivery a human asparaginase with lower allergic reactions and toxic effects, achieving a breakthrough milestone in the cancer treatment.

Vinicius Bastos (EyeTalk / Unicamp)
Express your feeling with your eyes.